AbbVie and Rice University Establish K.C. Nicolaou Research Accelerator to Advance Therapies in Oncology

11:12 EDT 1 May 2018 | Speciality Pharma Journal

NORTH CHICAGO, Ill. and HOUSTON, April 30, 2018 /PRNewswire/ — AbbVie, a research-based global biopharmaceutical company, and Rice University today announced they have entered into a joint research collaboration to establish the K.C. Nicolaou Research Accelerator. The research at the Accelerator will focus on synthesizing novel cytotoxic agents for use in the fight against cancer. …

More From BioPortfolio on "AbbVie and Rice University Establish K.C. Nicolaou Research Accelerator to Advance Therapies in Oncology"